Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New drug combo trial targets Tough-to-Treat throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) given before standard radiation and chemo in patients with advanced nasopharyngeal cancer. The goal was to see if this new drug sequence was safe and could shrink tumors more e…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Four-Pronged attack on liver cancer shows promise in trial
Disease control CompletedThis study tested a combination of four treatments for advanced liver cancer that cannot be removed by surgery. The approach involved delivering chemotherapy directly to the liver, blocking the tumor's blood supply, and adding two drugs (lenvatinib and tislelizumab) that target t…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC